nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone furoate—ABCB1—Sorafenib—liver cancer	0.19	0.389	CbGbCtD
Fluticasone furoate—ABCB1—Doxorubicin—liver cancer	0.115	0.236	CbGbCtD
Fluticasone furoate—CYP3A4—Sorafenib—liver cancer	0.114	0.233	CbGbCtD
Fluticasone furoate—CYP3A4—Doxorubicin—liver cancer	0.0689	0.141	CbGbCtD
Fluticasone furoate—Dysphonia—Sorafenib—liver cancer	0.00859	0.0489	CcSEcCtD
Fluticasone furoate—Blood pressure increased—Sorafenib—liver cancer	0.00707	0.0402	CcSEcCtD
Fluticasone furoate—Vaginal moniliasis—Epirubicin—liver cancer	0.00518	0.0294	CcSEcCtD
Fluticasone furoate—Vulvovaginal candidiasis—Epirubicin—liver cancer	0.00497	0.0283	CcSEcCtD
Fluticasone furoate—Vaginal moniliasis—Doxorubicin—liver cancer	0.00479	0.0272	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Epirubicin—liver cancer	0.00478	0.0272	CcSEcCtD
Fluticasone furoate—Vulvovaginal candidiasis—Doxorubicin—liver cancer	0.0046	0.0261	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Sorafenib—liver cancer	0.00459	0.0261	CcSEcCtD
Fluticasone furoate—Vulvovaginal mycotic infection—Doxorubicin—liver cancer	0.00442	0.0251	CcSEcCtD
Fluticasone furoate—Epistaxis—Sorafenib—liver cancer	0.00373	0.0212	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Sorafenib—liver cancer	0.00349	0.0198	CcSEcCtD
Fluticasone furoate—Immune system disorder—Sorafenib—liver cancer	0.00321	0.0182	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Sorafenib—liver cancer	0.0032	0.0182	CcSEcCtD
Fluticasone furoate—Dysphonia—Epirubicin—liver cancer	0.00317	0.0181	CcSEcCtD
Fluticasone furoate—Dysphonia—Doxorubicin—liver cancer	0.00294	0.0167	CcSEcCtD
Fluticasone furoate—Herpes simplex—Epirubicin—liver cancer	0.00283	0.0161	CcSEcCtD
Fluticasone furoate—Angioedema—Sorafenib—liver cancer	0.00282	0.0161	CcSEcCtD
Fluticasone furoate—Ulcer—Epirubicin—liver cancer	0.00276	0.0157	CcSEcCtD
Fluticasone furoate—Cough—Sorafenib—liver cancer	0.0027	0.0153	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Epirubicin—liver cancer	0.00269	0.0153	CcSEcCtD
Fluticasone furoate—Herpes simplex—Doxorubicin—liver cancer	0.00262	0.0149	CcSEcCtD
Fluticasone furoate—Ulcer—Doxorubicin—liver cancer	0.00256	0.0145	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Sorafenib—liver cancer	0.00252	0.0143	CcSEcCtD
Fluticasone furoate—Infection—Sorafenib—liver cancer	0.0025	0.0142	CcSEcCtD
Fluticasone furoate—Candida infection—Epirubicin—liver cancer	0.00249	0.0142	CcSEcCtD
Fluticasone furoate—Atrioventricular block—Doxorubicin—liver cancer	0.00249	0.0142	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Sorafenib—liver cancer	0.00247	0.0141	CcSEcCtD
Fluticasone furoate—Candida infection—Doxorubicin—liver cancer	0.00231	0.0131	CcSEcCtD
Fluticasone furoate—Dyspnoea—Sorafenib—liver cancer	0.00225	0.0128	CcSEcCtD
Fluticasone furoate—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.00223	0.00662	CbGpPWpGaD
Fluticasone furoate—NR3C1—Nuclear Receptors—PPARG—liver cancer	0.00219	0.0065	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.00215	0.00637	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.00213	0.00633	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—AHR—liver cancer	0.00212	0.00628	CbGpPWpGaD
Fluticasone furoate—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—liver cancer	0.00211	0.00626	CbGpPWpGaD
Fluticasone furoate—NR3C1—Nuclear Receptor transcription pathway—PPARA—liver cancer	0.00209	0.00622	CbGpPWpGaD
Fluticasone furoate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—liver cancer	0.00202	0.00598	CbGpPWpGaD
Fluticasone furoate—Urticaria—Sorafenib—liver cancer	0.002	0.0114	CcSEcCtD
Fluticasone furoate—Body temperature increased—Sorafenib—liver cancer	0.00199	0.0113	CcSEcCtD
Fluticasone furoate—ABCB1—Allograft Rejection—IL12A—liver cancer	0.00199	0.00591	CbGpPWpGaD
Fluticasone furoate—NR3C1—Circadian Clock—PPARA—liver cancer	0.00197	0.00585	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.00192	0.00569	CbGpPWpGaD
Fluticasone furoate—NR3C1—Nuclear Receptor transcription pathway—ESR1—liver cancer	0.0019	0.00563	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of Androgen receptor activity—MAPK14—liver cancer	0.00188	0.00557	CbGpPWpGaD
Fluticasone furoate—Migraine—Epirubicin—liver cancer	0.00187	0.0106	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Sorafenib—liver cancer	0.00186	0.0106	CcSEcCtD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CSF2—liver cancer	0.00185	0.0055	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.00184	0.00546	CbGpPWpGaD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—TNF—liver cancer	0.0018	0.00535	CbGpPWpGaD
Fluticasone furoate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—liver cancer	0.00175	0.0052	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.00174	0.00517	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—HNF4A—liver cancer	0.00174	0.00517	CbGpPWpGaD
Fluticasone furoate—NR3C1—Nuclear Receptor transcription pathway—PPARG—liver cancer	0.00173	0.00514	CbGpPWpGaD
Fluticasone furoate—Migraine—Doxorubicin—liver cancer	0.00173	0.00982	CcSEcCtD
Fluticasone furoate—Diarrhoea—Sorafenib—liver cancer	0.00173	0.00981	CcSEcCtD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.0017	0.00505	CbGpPWpGaD
Fluticasone furoate—Nasopharyngitis—Epirubicin—liver cancer	0.0017	0.00964	CcSEcCtD
Fluticasone furoate—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.00167	0.00496	CbGpPWpGaD
Fluticasone furoate—Dizziness—Sorafenib—liver cancer	0.00167	0.00948	CcSEcCtD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—CSF2—liver cancer	0.00163	0.00485	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.0016	0.00476	CbGpPWpGaD
Fluticasone furoate—Rash—Sorafenib—liver cancer	0.00159	0.00904	CcSEcCtD
Fluticasone furoate—Dermatitis—Sorafenib—liver cancer	0.00159	0.00903	CcSEcCtD
Fluticasone furoate—Headache—Sorafenib—liver cancer	0.00158	0.00898	CcSEcCtD
Fluticasone furoate—Bronchitis—Epirubicin—liver cancer	0.00158	0.00896	CcSEcCtD
Fluticasone furoate—Nasopharyngitis—Doxorubicin—liver cancer	0.00157	0.00892	CcSEcCtD
Fluticasone furoate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.00156	0.00462	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.00154	0.00457	CbGpPWpGaD
Fluticasone furoate—Nausea—Sorafenib—liver cancer	0.0015	0.00852	CcSEcCtD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—ESR1—liver cancer	0.00147	0.00437	CbGpPWpGaD
Fluticasone furoate—NR3C1—Circadian Clock—SERPINE1—liver cancer	0.00147	0.00436	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.00146	0.00433	CbGpPWpGaD
Fluticasone furoate—Bronchitis—Doxorubicin—liver cancer	0.00146	0.00829	CcSEcCtD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—IL6—liver cancer	0.00145	0.00431	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABL1—liver cancer	0.00142	0.00423	CbGpPWpGaD
Fluticasone furoate—NR3C1—Endoderm Differentiation—APC—liver cancer	0.00142	0.00423	CbGpPWpGaD
Fluticasone furoate—Conjunctivitis—Epirubicin—liver cancer	0.00142	0.00808	CcSEcCtD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00138	0.00409	CbGpPWpGaD
Fluticasone furoate—Epistaxis—Epirubicin—liver cancer	0.00138	0.00784	CcSEcCtD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—MAPK14—liver cancer	0.00132	0.00393	CbGpPWpGaD
Fluticasone furoate—Conjunctivitis—Doxorubicin—liver cancer	0.00131	0.00747	CcSEcCtD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—liver cancer	0.00131	0.00389	CbGpPWpGaD
Fluticasone furoate—Pharyngitis—Epirubicin—liver cancer	0.0013	0.0074	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Epirubicin—liver cancer	0.00129	0.00733	CcSEcCtD
Fluticasone furoate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.00129	0.00382	CbGpPWpGaD
Fluticasone furoate—Epistaxis—Doxorubicin—liver cancer	0.00128	0.00725	CcSEcCtD
Fluticasone furoate—Visual impairment—Epirubicin—liver cancer	0.00126	0.00719	CcSEcCtD
Fluticasone furoate—CYP3A4—Biological oxidations—UGDH—liver cancer	0.00125	0.00372	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL12B—liver cancer	0.00125	0.00371	CbGpPWpGaD
Fluticasone furoate—Eye disorder—Epirubicin—liver cancer	0.00123	0.00697	CcSEcCtD
Fluticasone furoate—Pharyngitis—Doxorubicin—liver cancer	0.0012	0.00685	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Doxorubicin—liver cancer	0.00119	0.00678	CcSEcCtD
Fluticasone furoate—NR3C1—Regulation of Androgen receptor activity—JUN—liver cancer	0.00119	0.00353	CbGpPWpGaD
Fluticasone furoate—Immune system disorder—Epirubicin—liver cancer	0.00118	0.00674	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Epirubicin—liver cancer	0.00118	0.00672	CcSEcCtD
Fluticasone furoate—Visual impairment—Doxorubicin—liver cancer	0.00117	0.00665	CcSEcCtD
Fluticasone furoate—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.00115	0.0034	CbGpPWpGaD
Fluticasone furoate—Eye disorder—Doxorubicin—liver cancer	0.00113	0.00645	CcSEcCtD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—HMOX1—liver cancer	0.00113	0.00336	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CDKN2A—liver cancer	0.00113	0.00335	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of Androgen receptor activity—MAPK8—liver cancer	0.00113	0.00334	CbGpPWpGaD
Fluticasone furoate—Back pain—Epirubicin—liver cancer	0.0011	0.00628	CcSEcCtD
Fluticasone furoate—Immune system disorder—Doxorubicin—liver cancer	0.0011	0.00623	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Doxorubicin—liver cancer	0.00109	0.00622	CcSEcCtD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—liver cancer	0.00108	0.0032	CbGpPWpGaD
Fluticasone furoate—Agitation—Epirubicin—liver cancer	0.00105	0.00597	CcSEcCtD
Fluticasone furoate—Back pain—Doxorubicin—liver cancer	0.00102	0.00581	CcSEcCtD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—NR1H4—liver cancer	0.00101	0.003	CbGpPWpGaD
Fluticasone furoate—Palpitations—Epirubicin—liver cancer	0.00101	0.00574	CcSEcCtD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CDKN1B—liver cancer	0.001	0.00297	CbGpPWpGaD
Fluticasone furoate—Cough—Epirubicin—liver cancer	0.000996	0.00567	CcSEcCtD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—NR1I3—liver cancer	0.000993	0.00295	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—PPARA—liver cancer	0.000991	0.00294	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00098	0.00291	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00098	0.00291	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IL2—liver cancer	0.00098	0.00291	CbGpPWpGaD
Fluticasone furoate—Agitation—Doxorubicin—liver cancer	0.000971	0.00552	CcSEcCtD
Fluticasone furoate—NR3C1—Endoderm Differentiation—CTNNB1—liver cancer	0.000968	0.00287	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000959	0.00285	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—FST—liver cancer	0.000958	0.00284	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CCND1—liver cancer	0.000955	0.00283	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—JUN—liver cancer	0.000953	0.00283	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CTNNB1—liver cancer	0.000946	0.00281	CbGpPWpGaD
Fluticasone furoate—Palpitations—Doxorubicin—liver cancer	0.000934	0.00531	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Epirubicin—liver cancer	0.000932	0.0053	CcSEcCtD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—TERT—liver cancer	0.00093	0.00276	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MMP9—liver cancer	0.000927	0.00275	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000926	0.00275	CbGpPWpGaD
Fluticasone furoate—Infection—Epirubicin—liver cancer	0.000926	0.00527	CcSEcCtD
Fluticasone furoate—Cough—Doxorubicin—liver cancer	0.000922	0.00524	CcSEcCtD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000914	0.00271	CbGpPWpGaD
Fluticasone furoate—Nervous system disorder—Epirubicin—liver cancer	0.000914	0.0052	CcSEcCtD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IL2—liver cancer	0.000863	0.00256	CbGpPWpGaD
Fluticasone furoate—Anaphylactic shock—Doxorubicin—liver cancer	0.000862	0.0049	CcSEcCtD
Fluticasone furoate—Infection—Doxorubicin—liver cancer	0.000857	0.00487	CcSEcCtD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—liver cancer	0.000848	0.00252	CbGpPWpGaD
Fluticasone furoate—Nervous system disorder—Doxorubicin—liver cancer	0.000846	0.00481	CcSEcCtD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—JUN—liver cancer	0.00084	0.00249	CbGpPWpGaD
Fluticasone furoate—Dyspnoea—Epirubicin—liver cancer	0.000831	0.00473	CcSEcCtD
Fluticasone furoate—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000823	0.00244	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—liver cancer	0.000822	0.00244	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—PPARG—liver cancer	0.000819	0.00243	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—liver cancer	0.000814	0.00242	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—liver cancer	0.000794	0.00236	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000792	0.00235	CbGpPWpGaD
Fluticasone furoate—NR3C1—Endoderm Differentiation—TGFB1—liver cancer	0.000782	0.00232	CbGpPWpGaD
Fluticasone furoate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—liver cancer	0.00077	0.00229	CbGpPWpGaD
Fluticasone furoate—Dyspnoea—Doxorubicin—liver cancer	0.000769	0.00437	CcSEcCtD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MYC—liver cancer	0.000766	0.00227	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—TGFB1—liver cancer	0.000764	0.00227	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000751	0.00223	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—liver cancer	0.000745	0.00221	CbGpPWpGaD
Fluticasone furoate—Urticaria—Epirubicin—liver cancer	0.00074	0.00421	CcSEcCtD
Fluticasone furoate—NR3C1—Adipogenesis—SERPINE1—liver cancer	0.000738	0.00219	CbGpPWpGaD
Fluticasone furoate—Body temperature increased—Epirubicin—liver cancer	0.000737	0.00419	CcSEcCtD
Fluticasone furoate—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000732	0.00217	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—liver cancer	0.00073	0.00217	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.00072	0.00214	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—liver cancer	0.000715	0.00212	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.00071	0.00211	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—HNF4A—liver cancer	0.000689	0.00204	CbGpPWpGaD
Fluticasone furoate—Hypersensitivity—Epirubicin—liver cancer	0.000687	0.0039	CcSEcCtD
Fluticasone furoate—Urticaria—Doxorubicin—liver cancer	0.000685	0.0039	CcSEcCtD
Fluticasone furoate—Body temperature increased—Doxorubicin—liver cancer	0.000682	0.00388	CcSEcCtD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—liver cancer	0.000682	0.00202	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—liver cancer	0.000682	0.00202	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000665	0.00197	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000658	0.00195	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000657	0.00195	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000649	0.00193	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000642	0.0019	CbGpPWpGaD
Fluticasone furoate—Diarrhoea—Epirubicin—liver cancer	0.000638	0.00363	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Doxorubicin—liver cancer	0.000635	0.00361	CcSEcCtD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—TP53—liver cancer	0.000629	0.00187	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000619	0.00184	CbGpPWpGaD
Fluticasone furoate—Dizziness—Epirubicin—liver cancer	0.000616	0.0035	CcSEcCtD
Fluticasone furoate—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000612	0.00182	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—EXOSC2—liver cancer	0.000611	0.00181	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000604	0.00179	CbGpPWpGaD
Fluticasone furoate—Diarrhoea—Doxorubicin—liver cancer	0.00059	0.00336	CcSEcCtD
Fluticasone furoate—Rash—Epirubicin—liver cancer	0.000588	0.00334	CcSEcCtD
Fluticasone furoate—Dermatitis—Epirubicin—liver cancer	0.000587	0.00334	CcSEcCtD
Fluticasone furoate—Headache—Epirubicin—liver cancer	0.000584	0.00332	CcSEcCtD
Fluticasone furoate—NR3C1—Adipogenesis—CTNNB1—liver cancer	0.000576	0.00171	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IL6—liver cancer	0.000576	0.00171	CbGpPWpGaD
Fluticasone furoate—Dizziness—Doxorubicin—liver cancer	0.00057	0.00324	CcSEcCtD
Fluticasone furoate—NR3C1—Adipogenesis—CDKN1A—liver cancer	0.000563	0.00167	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—TP53—liver cancer	0.000554	0.00164	CbGpPWpGaD
Fluticasone furoate—Nausea—Epirubicin—liver cancer	0.000554	0.00315	CcSEcCtD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—liver cancer	0.000547	0.00162	CbGpPWpGaD
Fluticasone furoate—Rash—Doxorubicin—liver cancer	0.000544	0.00309	CcSEcCtD
Fluticasone furoate—Dermatitis—Doxorubicin—liver cancer	0.000543	0.00309	CcSEcCtD
Fluticasone furoate—Headache—Doxorubicin—liver cancer	0.00054	0.00307	CcSEcCtD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000539	0.0016	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—JUN—liver cancer	0.000537	0.00159	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—CASP3—liver cancer	0.000517	0.00153	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000513	0.00152	CbGpPWpGaD
Fluticasone furoate—Nausea—Doxorubicin—liver cancer	0.000512	0.00291	CcSEcCtD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IL6—liver cancer	0.000507	0.00151	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—STAT3—liver cancer	0.000502	0.00149	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—JUN—liver cancer	0.000502	0.00149	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000502	0.00149	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—liver cancer	0.000498	0.00148	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000489	0.00145	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—NR1H4—liver cancer	0.000486	0.00144	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—liver cancer	0.00048	0.00142	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000479	0.00142	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CASP3—liver cancer	0.000478	0.00142	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—NR1I3—liver cancer	0.000478	0.00142	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL2—liver cancer	0.000478	0.00142	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—liver cancer	0.000473	0.0014	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—liver cancer	0.000469	0.00139	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—liver cancer	0.000468	0.00139	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—TGFB1—liver cancer	0.000466	0.00138	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000459	0.00136	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000459	0.00136	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—VEGFA—liver cancer	0.000438	0.0013	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—TNF—liver cancer	0.000435	0.00129	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000434	0.00129	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—liver cancer	0.000412	0.00122	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—VEGFA—liver cancer	0.000406	0.0012	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000399	0.00118	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000393	0.00117	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—TNF—liver cancer	0.000376	0.00112	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—TGFB1—liver cancer	0.000373	0.00111	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000366	0.00109	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—PPARA—liver cancer	0.000362	0.00107	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—liver cancer	0.000361	0.00107	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—liver cancer	0.000354	0.00105	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—IL6—liver cancer	0.000351	0.00104	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—TNF—liver cancer	0.000348	0.00103	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—UGDH—liver cancer	0.000348	0.00103	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—APC—liver cancer	0.000335	0.000994	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—HNF4A—liver cancer	0.000331	0.000984	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000329	0.000976	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—ESR1—liver cancer	0.000328	0.000973	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—EPT1—liver cancer	0.000327	0.000971	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000324	0.000963	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—TAT—liver cancer	0.00031	0.00092	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL6—liver cancer	0.000303	0.0009	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000302	0.000897	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	0.000299	0.000888	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—PPARG—liver cancer	0.000299	0.000887	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000298	0.000885	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—PSMA4—liver cancer	0.00029	0.00086	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—PSMD10—liver cancer	0.00029	0.00086	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000287	0.00085	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000283	0.000839	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—SERPINE1—liver cancer	0.000269	0.000799	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	0.000263	0.00078	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	0.000241	0.000715	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	0.000236	0.000701	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	0.00023	0.000682	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	0.000229	0.000681	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	0.000228	0.000675	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	0.000222	0.00066	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000221	0.000656	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	0.000217	0.000644	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—UGDH—liver cancer	0.000214	0.000636	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CPT1B—liver cancer	0.000211	0.000626	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GLUL—liver cancer	0.000211	0.000626	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—NR1H4—liver cancer	0.000203	0.000603	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—EPT1—liver cancer	0.000201	0.000598	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	0.0002	0.000595	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTA3—liver cancer	0.0002	0.000593	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—H2AFX—liver cancer	0.000196	0.000581	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000192	0.000571	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—TAT—liver cancer	0.000191	0.000567	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	0.000184	0.000547	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	0.000184	0.000546	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTA4—liver cancer	0.000183	0.000542	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTA2—liver cancer	0.000178	0.000529	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—PPARA—liver cancer	0.000174	0.000517	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTA1—liver cancer	0.000172	0.00051	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	0.000172	0.00051	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—MYC—liver cancer	0.00017	0.000506	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	0.00017	0.000506	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—NAT2—liver cancer	0.00017	0.000504	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ALDOB—liver cancer	0.000163	0.000483	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—MAPK14—liver cancer	0.000161	0.000477	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—ESR1—liver cancer	0.000158	0.000468	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	0.000156	0.000464	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CRABP1—liver cancer	0.000155	0.000461	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000155	0.000461	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	0.000151	0.000449	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—PPARG—liver cancer	0.000144	0.000427	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—HPGDS—liver cancer	0.000136	0.000403	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CPT1B—liver cancer	0.00013	0.000385	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GLUL—liver cancer	0.00013	0.000385	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—SERPINE1—liver cancer	0.00013	0.000385	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	0.000128	0.000379	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—NR1H4—liver cancer	0.000125	0.000372	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTA3—liver cancer	0.000123	0.000365	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PSMD10—liver cancer	0.000121	0.000359	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PSMA4—liver cancer	0.000121	0.000359	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GOT2—liver cancer	0.000118	0.000349	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	0.000115	0.000343	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTA4—liver cancer	0.000113	0.000334	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP2E1—liver cancer	0.000111	0.000329	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTA2—liver cancer	0.00011	0.000326	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTA1—liver cancer	0.000106	0.000314	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—NAT2—liver cancer	0.000105	0.000311	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000104	0.00031	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYCS—liver cancer	0.000104	0.000307	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GGT1—liver cancer	0.000102	0.000302	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GOT1—liver cancer	0.000102	0.000302	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ALDOB—liver cancer	0.0001	0.000298	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CRABP1—liver cancer	9.57e-05	0.000284	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTP1—liver cancer	9.13e-05	0.000271	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—HMOX1—liver cancer	9e-05	0.000267	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTM1—liver cancer	8.39e-05	0.000249	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—HPGDS—liver cancer	8.37e-05	0.000248	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—MYC—liver cancer	8.21e-05	0.000244	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP1A1—liver cancer	7.95e-05	0.000236	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PSMA4—liver cancer	7.46e-05	0.000221	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PSMD10—liver cancer	7.46e-05	0.000221	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—MTHFR—liver cancer	7.41e-05	0.00022	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PPARA—liver cancer	7.27e-05	0.000216	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GOT2—liver cancer	7.25e-05	0.000215	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP2E1—liver cancer	6.82e-05	0.000202	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYCS—liver cancer	6.38e-05	0.000189	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GOT1—liver cancer	6.26e-05	0.000186	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GGT1—liver cancer	6.26e-05	0.000186	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CG—liver cancer	6.23e-05	0.000185	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PPARG—liver cancer	6.01e-05	0.000178	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—AKT1—liver cancer	5.69e-05	0.000169	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTP1—liver cancer	5.62e-05	0.000167	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—HMOX1—liver cancer	5.55e-05	0.000165	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CD—liver cancer	5.48e-05	0.000163	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ALB—liver cancer	5.41e-05	0.00016	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTM1—liver cancer	5.17e-05	0.000153	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP1A1—liver cancer	4.9e-05	0.000145	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CB—liver cancer	4.77e-05	0.000142	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—MTHFR—liver cancer	4.57e-05	0.000136	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PPARA—liver cancer	4.48e-05	0.000133	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CG—liver cancer	3.84e-05	0.000114	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PPARG—liver cancer	3.7e-05	0.00011	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CD—liver cancer	3.37e-05	0.0001	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ALB—liver cancer	3.33e-05	9.89e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CB—liver cancer	2.94e-05	8.73e-05	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CA—liver cancer	2.91e-05	8.64e-05	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—AKT1—liver cancer	2.38e-05	7.06e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CA—liver cancer	1.79e-05	5.32e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—AKT1—liver cancer	1.46e-05	4.35e-05	CbGpPWpGaD
